Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-052972

Chief Development Officer sold 988 shares at $21.64 ($21,380)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Curley Joanne Chief Development Officer 2022-10-05 Sale −988 $21.64 $21,380 27,809 D: show line 1 in the form
Open-market sales · 988 sh · avg $21.64 · $21,380
Loading xslF345X03/doc4.xml…